What type of lung cancer is Vizimpro used to treat?
Medically reviewed by Drugs.com. Last updated on Oct 28, 2020.
Official answer
by Drugs.comVizimpro is taken for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC).
Vizimpro (dacomitinib) from Pfizer is an oral, once-daily kinase inhibitor that targets two lung cancer biomarkers, both detected by an FDA-approved test. These two targets are:- Epidermal growth factor receptor (EGFR) exon 19 deletion mutations
- EGFR exon 21 L858R substitution mutations.
Other EGFR inhibitors that may be used in the treatment of NSCLC include:
Related medical questions
- What is the strongest chemotherapy drug for breast cancer?
- Is small cell or non-small cell lung cancer worse?
- What type of prostate cancer is Erleada used to treat?
- What type of cancer is Tecentriq used to treat?
- What type of cancer is Daurismo (glasdegib) used to treat?
Drug information
Related support groups
- Vizimpro (1 questions, 3 members)
- Dacomitinib (1 questions, 3 members)
- Cancer (141 questions, 621 members)
- Non-Small Cell Lung Cancer (34 questions, 67 members)
- Lung Cancer (10 questions, 38 members)